Additionally, IL‐6 is suggested to contribute to the mitochondrial abnormalities associated with tumour growth, as neutralising IL‐6 antibodies restored altered peroxisome proliferator‐activated receptor‐gamma coactivator (PGC)‐1α levels and mitochondrial content (White et al., 2012). The gene discussed is IL6; the disease is neoplasm.